Artículos

Artículos Encontrados 80 registros  inicioanterior17 - 26siguientefinal  ir al registro: La búsqueda tardó 0.00 segundos. 
17.
12 p, 3.7 MB Minimum Effective Dose of DPP-4 Inhibitors for Treating Early Stages of Diabetic Retinopathy in an Experimental Model / Bogdanov, Patricia (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ; Ramos, Hugo (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ; Valeri, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Deàs-Just, Anna (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Huerta, Jordi (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Simó Canonge, Rafael (Universitat Autònoma de Barcelona. Departament de Medicina) ; Hernández, Cristina (Universitat Autònoma de Barcelona. Departament de Medicina)
The neurovascular unit (NVU) plays an essential role in the development of diabetic retinopathy (DR). We previously reported that the topical administration (eye drops) of sitagliptin and saxagliptin, two dipeptidyl peptidase-4 inhibitors (DPP-4i), prevents retinal neurodegeneration and vascular leakage in db/db mice. [...]
2022 - 10.3390/biomedicines10020465
Biomedicines, Vol. 10 (february 2022)  
18.
16 p, 17.3 MB Decreased endostatin in db/db retinas is associated with optic disc intravitreal vascularization / Bonet, Aina (Universitat Autònoma de Barcelona. Departament de Sanitat i d'Anatomia Animals) ; Valença, Andreia (Universidade de Lisboa. Centre for Interdisciplinary Research in Animal Health) ; Mendes-Jorge, Luisa (Universidade de Lisboa. Centre for Interdisciplinary Research in Animal Health) ; Casellas, Alba (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ; Rodríguez Baeza, Alfonso (Universitat Autònoma de Barcelona. Departament de Ciències Morfològiques) ; Nacher García, Víctor (Universitat Autònoma de Barcelona. Departament de Sanitat i d'Anatomia Animals) ; Ramos González, David (Universidade de Lisboa. Centre for Interdisciplinary Research in Animal Health) ; Pampalona Sala, Judit (Universitat Autònoma de Barcelona. Centre de Biotecnologia Animal i de Teràpia Gènica (CBATEG)) ; Simó Canonge, Rafael (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Ruberte, Jesús (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas)
Endostatin, a naturally cleaved fragment of type XVIII collagen with antiangiogenic activity, has been involved in the regulation of neovascularization during diabetic retinopathy. Here, the intracellular distribution of endostatin in healthy mouse and human neuroretinas has been analyzed. [...]
2021 - 10.1016/j.exer.2021.108801
Experimental Eye Research, Vol. 212 (november 2021) , p. 108801  
19.
10 p, 2.4 MB Effects of the topical administration of semaglutide on retinal neuroinflammation and vascular leakage in experimental diabetes / Simó Canonge, Rafael (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Bogdanov, Patricia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Ramos, Hugo (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Huerta, Jordi (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Simó-Servat, Olga (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Hernández, Cristina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
Background: An unexpected increase in the rate of severe diabetic retinopathy was observed in the Semaglutide in Subjects with Type 2 Diabetes (SUSTAIN)-6 clinical trial. Although this effect was attributed to a rapid decrease in blood glucose levels, a direct deleterious effect of semaglutide on the retina could not be ruled out. [...]
2021 - 10.3390/biomedicines9080926
Biomedicines, Vol. 9 Núm. 8 (august 2021) , p. 926  
20.
6 p, 269.9 KB Phagocytic Activity Is Impaired in Type 2 Diabetes Mellitus and Increases after Metabolic Improvement / Lecube, Albert (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Pachón, Gisela (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Petriz, Jordi (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Hernández, Cristina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Simó Canonge, Rafael (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
1) To evaluate whether peripheral blood mononuclear cells (PBMCs) from type 2 diabetic patients present an impairment of phagocytic activity; 2) To determine whether the eventual impairment in phagocytic activity is related to glycemic control and can be reversed by improving blood glucose levels. [...]
2011 - 10.1371/journal.pone.0023366
PloS one, Vol. 6 (august 2011)  
21.
7 p, 243.4 KB Diabetes Is the Main Factor Accounting for Hypomagnesemia in Obese Subjects / Lecube, Albert (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Baena-Fustegueras, Juan Antonio (Hospital Universitari Vall d'Hebron) ; Fort, José Manuel (Hospital Universitari Vall d'Hebron) ; Pelegrí-Sisó, Dolors (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Hernández, Cristina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Simó Canonge, Rafael (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
Type 2 diabetes (T2DM) and obesity are associated with magnesium deficiency. We aimed to determine whether the presence of type 2 diabetes and the degree of metabolic control are related to low serum magnesium levels in obese individuals. [...]
2012 - 10.1371/journal.pone.0030599
PloS one, Vol. 7 (january 2012)  
22.
8 p, 368.4 KB Impact of Glucose-Lowering Agents on the Risk of Cancer in Type 2 Diabetic Patients. The Barcelona Case-Control Study / Simó Canonge, Rafael (Universitat Autònoma de Barcelona. Departament de Medicina) ; Plana-Ripoll, Oleguer (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Puente, Diana (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Morros, Rosa (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Mundet-Tudurí, Xavier (Universitat Autònoma de Barcelona. Departament de Medicina) ; Vilca Yengle, Luz María (Hospital Universitari Vall d'Hebron) ; Hernández, Cristina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Fuentes Camps, Inmaculada (Hospital Universitari Vall d'Hebron) ; Procupet, Adriana (Institut Català de la Salut) ; Tabernero, Josep (Universitat Autònoma de Barcelona. Departament de Medicina) ; Violán, Concepció (Institut Universitari d'Investigació en Atenció Primària Jordi Gol)
The aim of the present study is to evaluate the impact of glucose-lowering agents in the risk of cancer in a large type 2 diabetic population. A nested case-control study was conducted within a defined cohort (275,164 type 2 diabetic patients attending 16 Primary Health Care Centers of Barcelona). [...]
2013 - 10.1371/journal.pone.0079968
PloS one, Vol. 8 (november 2013)  
23.
12 p, 11.3 MB Diabetes Protects from Prostate Cancer by Downregulating Androgen Receptor : New Insights from LNCaP Cells and PAC120 Mouse Model / Barbosa-Desongles, Anna (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Hernández, Cristina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; de Torres, Inés (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Munell Casadesus, Francina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Poupon, Marie-France (Institut Curie) ; Simó Canonge, Rafael (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Martínez Selva, David (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
Type 2 diabetes has been associated with decreased risk of prostate cancer in observational studies, and this inverse association has been recently confirmed in several large cohort studies. However the mechanisms involved in this protective effect remain to be elucidated. [...]
2013 - 10.1371/journal.pone.0074179
PloS one, Vol. 8 (september 2013)  
24.
5 p, 251.5 KB Variables Involved in the Discordance between HbA1c and Fructosamine : The Glycation Gap Revisited / Zafón, Carles (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Ciudin, Andreea (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Mesa Manteca, Jordi (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Valladares, Silvia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Simó Canonge, Rafael (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
Glycation gap (GG) is defined as the difference between the measured level of HbA1c and the level that would be predicted from its regression on the fructosamine level. The aims of the study were: 1) To determine the reproducibility and consistency of GC; 2) To discover factors related to GG value. [...]
2013 - 10.1371/journal.pone.0066696
PloS one, Vol. 8 (june 2013)  
25.
8 p, 629.6 KB Thyroid Hormone Upregulates Zinc-α-glycoprotein Production in the Liver but Not in Adipose Tissue / Simó Canonge, Rafael (Universitat Autònoma de Barcelona. Departament de Medicina) ; Hernández, Cristina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Sáez-López, Cristina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Soldevila i Madorell, Berta (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Puig Domingo, Manuel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Martínez Selva, David (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona. Departament de Medicina
Overproduction of zinc-α-glycoprotein by adipose tissue is crucial in accounting for the lipolysis occurring in cancer cachexia of certain malignant tumors. The main aim of this study was to explore whether thyroid hormone could enhance zinc-α-glycoprotein production in adipose tissue. [...]
2014 - 10.1371/journal.pone.0085753
PloS one, Vol. 9 (january 2014)  
26.
9 p, 162.2 KB Characterization of Sleep Breathing Pattern in Patients with Type 2 Diabetes : Sweet Sleep Study / Lecube, Albert (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Sampol, Gabriel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Hernández, Cristina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Romero, Odile (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Ciudin, Andreea (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Simó Canonge, Rafael (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
Although sleep apnea-hypopnea syndrome (SAHS) is highly prevalent in patients with type 2 diabetes (T2D), it is unknown whether or not subjects with and without T2D share the same sleep breathing pattern. [...]
2015 - 10.1371/journal.pone.0119073
PloS one, Vol. 10 (march 2015)  

Artículos : Encontrados 80 registros   inicioanterior17 - 26siguientefinal  ir al registro:
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.